Andromeda Surgical Expands its Market Reach

Andromeda Surgical has forged strategic partnerships with Richard Wolf and Quanta System to foster its growth and expand access to its minimally invasive robotic solutions.

Andromeda’s robotic system is designed to be the first of its kind with constantly improving software, enabling continuous advancements in surgical precision, efficiency, and adaptability over time. This approach ensures that surgeons will always have access to the latest innovations without needing entirely new hardware.

The system’s first clinical application is Holmium Laser Enucleation of the Prostate (HoLEP), a gold-standard procedure for treating benign prostatic hyperplasia (BPH). However, Andromeda’s technology is designed for scalability and will expand into multiple surgical specialties and disease states in the near future.

Since launching its clinical program, Andromeda has already completed 15 successful procedures in Chile and New Zealand in its ASTRA clinical study, underscoring the company’s rapid execution and real-world impact. Prof. Peter Gilling, a world-renowned urologist who pioneered the HoLEP procedure, is the lead principal investigator of the ASTRA Study.

“At Andromeda Surgical, we are moving at an unprecedented pace to redefine the future of robotic surgery,” Andromeda Surgical Co-Founder/CEO Nick Damiano said. “Partnering with Richard Wolf and Quanta System allows us to deliver a fully integrated solution that advances surgical precision and enhances patient outcomes. With a constantly improving software platform and an expanding range of clinical applications, we are building the future of surgical robotics.”

The collaboration with Richard Wolf, a provider of in endoscopic imaging and surgical instrumentation, ensures that Andromeda’s robotic system is optimized with best-in-class visualization technologies.

“Andromeda Surgical is bringing a groundbreaking approach to robotic-assisted surgery, and we are thrilled to be part of this journey,” Richard Wolf Co-CEO Jürgen Steinbeck stated. “Together, we will equip surgeons with the most advanced tools available, driving better patient care and expanding access to minimally invasive procedures.”

The partnership with Quanta System, a global leader in laser technology, further strengthens Andromeda’s capabilities. Quanta’s holmium laser technology is integral to HoLEP, ensuring precise and efficient tissue removal.

“Our collaboration with Andromeda Surgical is a perfect match,” Quanta System CEO Girolamo Lionetti commented. “By integrating our laser technology with Andromeda’s robotic platform, we are setting a new standard for HoLEP and paving the way for broader applications in surgical robotics.”

Andromeda Surgical is a South San Francisco, Calif.-based company developing autonomous surgical robots, starting with endourology procedures. The company’s is striving to make the difficult parts of surgery easy and empower every surgeon to deliver optimal patient outcomes in every procedure. The team combines expertise from medtech, autonomous vehicles, and other robotics and AI applications, working in conjunction with top global urologists.

Richard Wolf is a full-service provider in endoscopy, offering a wide range of instrumentation and system solutions for minimally invasive medicine. The company has more than 16 subsidiaries and 130 distributors.

Founded in 1985, Quanta System is part of El.En. SpA, an Italian designer of laser systems and gold standard solutions for surgery, dermatology, and aesthetics.